NEI Research News

The September 14 workshop brought together multidisciplinary experts in extracellular vesicles – cell-secreted nanoparticles that mediate cell-cell communication.

Relatively short-term use of immunosuppressant medications to control an inflammatory disease was not associated with an increased risk of later developing cancer, according to new research.

Study from UT Southwestern Medical Center could lead to new treatments for deadly childhood eye cancer.

Did you know the sun's ultraviolet (UV) rays can also damage the eyes? Here are some common questions and answers about UV light and how to protect your eyes from the sun.

The AREDS2 formula not only reduces risk of lung cancer due to beta-carotene, but is also more effective at reducing risk of AMD progression, compared to the original formula.

Scientists at St. Jude Children’s Research Hospital have created a laboratory model for studying retinoblastoma driven by inherited mutations in the RB1 gene.

Researchers at UAB have discovered a small molecule inhibitor that dampens the potent drivers of uveal melanoma.

A study by researchers at Washington University School of Medicine in St. Louis and Stanford University School of Medicine shows that the normal day-to-day activity of neurons can drive the formation and growth of brain tumors.

A treatment that uses immune system T-cells, combined with an immune-boosting drug packaged in an injectable gel, was found to preserve the vision of mice implanted with tissue from a human eye cancer known as retinoblastoma.

Researchers have found that the survival rates for two alternative treatments for primary eye cancer–radiation therapy and removal of the eye–are about the same.